Rieger Hans-Jürgen
Z Arztl Fortbild Qualitatssich. 2005 Apr;99(2):161-4; discussion 166, 168.
The financing of advanced medical training for physicians by the pharmaceutical industry has been the subject of legal discussions for more than two decades. Recent legal changes have renewed the importance of industry sponsoring. At the 106th national convention of the German physicians, the model ordinance for the German medical profession ("Musterberufsordnung für die deutschen Arztinnen und Arzte-MBO-A") has been reformed, and for the first time individual physicians are now permitted, under certain circumstances, to receive financial support from sponsors to participate in medical-training events. A recent legal reform to modernize the healthcare system ("GKV-Modernisierungsgesetz"--GMG) obliges physicians to observe the law that regulates advertising of medicinal products ("Heilmittelwerbegesetz"--HWG); consequently, the physicians can commit a misdemeanor when accepting prohibited financial support. This essay discusses the implications of this legal reform for the most important types of commercially-sponsored medical training. The GMG reform has introduced an obligation for physicians to absolve continuous medical training, however the resulting legal situation has not changed the requirement that this training remain free of commercial interests.
二十多年来,制药行业为医生提供高级医学培训的资金一直是法律讨论的主题。最近的法律变革再次凸显了行业赞助的重要性。在德国医生第106届全国大会上,德国医学专业的示范条例(“德国医生示范职业条例-MBO-A”)进行了改革,现在首次允许个别医生在某些情况下接受赞助商的资金支持以参加医学培训活动。最近一项旨在使医疗保健系统现代化的法律改革(“法定医疗保险现代化法案-GMG”)要求医生遵守规范药品广告的法律(“药品广告法-HWG”);因此,医生在接受被禁止的资金支持时可能会构成轻罪。本文讨论了这项法律改革对最重要的商业赞助医学培训类型的影响。GMG改革引入了医生必须完成继续医学培训的义务,然而由此产生的法律状况并未改变培训应保持无商业利益的要求。